Le Lézard
Classified in: Health, Business
Subjects: CXP, MAT

Quality of Life Medical & Research Center Offers GAINSWave® in Tucson


TUCSON, Ariz., July 10, 2018 /PRNewswire/ -- Quality of Life Medical & Research Center is pleased to announce they now offer GAINSWave! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction (ED) symptoms.

GAINSWave Logo (PRNewsfoto/GAINSWave)

As men age, the vessels in their penis weaken, contract and fill with micro-plaque, which can lead to Erectile Dysfunction. As these tiny vessels become clogged, the penis decreases in sensitivity, making it harder for men to achieve and maintain an erection. Thankfully, the GAINSWave protocols can enhance a man's performance by using high-frequency acoustic waves to repair existing blood vessels and improve blood flow.

Thanks to the numerous  clinical studies on Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT), we can see that this therapy improves not only Erectile Dysfunction symptoms but also sexual performance. "GAINSWave is an ideal solution for men looking to improve spontaneous erections without the use of Viagra or Cialis," says John McGettigan, MD. Patients receiving GAINSWave therapy have reported improved erection quality, enhanced sexual performance and decreased refractory times between orgasms, which is why this a great alternative to ED medications.

This drug and surgery-free procedure only takes about 20 minutes and can enhance a man's sex life while addressing the root cause of Erectile Dysfunction. Quality of Life Medical & Research Center is now treating men with the GAINSWave Therapy in their offices located at 5390 East Erickson Drive, Tucson, AZ, USA.

Dr. McGettigan "Jack", is the founder and driving force behind his private practice Qualify of Life Medical Center (QLMC), and Quality of Life Medical & Research Center (QLMRC). He is a graduate of Emory Medical School in Atlanta, Georgia. After moving to Tucson, Dr. McGettigan attended the University of Arizona, and trained as a General Surgeon before specializing in Emergency Medicine.

Dr. McGettigan specializes in Men's Health and General Medicine. Over the past 18 years, Dr. McGettigan has been a principal investigator for over 200 clinical trials focusing on men and women's health, as well as variety of different treatment research and biomedical clinical trials. Dr. McGettigan is a certified BioTE provider treating men and women.

For More Information Contact:
Alexandra Schapiro
Marketing Account Manager
[email protected]
305-918-1886

 

SOURCE GAINSWave


These press releases may also interest you

at 11:00
PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam's appointment follows an extensive...

at 10:36
Senstar Technologies Corporation , a leading international provider of comprehensive physical, video and access control security products and solutions, announced today that its Annual Report on Form 20-F for the year ended December 31, 2023 has been...

at 10:33
The report titled "Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic Hormone, Calcitonin, Insulin), Route of Administration, Application, End User, Manufacturing Type - Global...

at 10:30
KLOwen Orthodontics continues to lead innovation in the orthodontic industry by launching at AAO, the only custom metal self-ligating (SL) solution available and a 2024 Ortho Innovator Honorable Mention recipient....

at 10:30
For the roughly 1.5 million Americans per year who survive a traumatic brain injury, health outcomes vary widely. Not only can these injuries lead to a loss of...

at 10:18
Richards Packaging Income Fund (the "Fund") announced today its cash distribution for the month ended April 30, 2024 of Cdn$0.11 per unit. This distribution will be to unitholders of record at the close of business on April 30, 2024 and will be...



News published on and distributed by: